Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part

被引：2
|
作者：
Hebbar, M. [1 ]
Heurgue-Berlot, A. [2 ]
Boige, V. [3 ]
Le Malicot, K. [4 ]
Bernard-Chabert, B. [2 ]
Marcus, C. [5 ]
Dharancy, S. [6 ]
Sergent, G. [7 ]
Perarnau, J. M. [8 ]
Ehrhard, F. [9 ]
Ollivier-Hourmand, I. [10 ]
Vergniol, J. [11 ]
Michel, P. [12 ]
Edeline, J. [13 ]
Rinaldi, Y. [14 ]
Seitz, J. F. [15 ]
Lepage, C. [16 ]
De Baere, T. [17 ]
机构：
[1] Ctr Hosp Huriez, Med Oncol, Lille, France
[2] Univ Hosp, Hepatol, Reims, France
[3] Gustave Roussy, Digest Oncol, Villejuif, France
[4] Federat Francophone Cancerol Digest, Biostat, Dijon, France
[5] Univ Hosp, Radiol, Reims, France
[6] Ctr Hosp Huriez, Hepatol, Lille, France
[7] Ctr Hosp Huriez, Radiol, Lille, France
[8] Univ Hosp, Gastroenterol, Tours, France
[9] Univ Hosp, Gastroenterol, Reims, France
[10] Univ Hosp, Gastroenterol, Caen, France
[11] Univ Hosp, Gastroenterol, Pessac, France
[12] Univ Hosp, Gastroenterol, Rouen, France
[13] Anticanc Ctr, Oncol, Rennes, France
[14] Hop Ambroise Pare, Gastroenterol, Marseille, France
[15] La Timone Univ Hosp, Digest Oncol, Marseille, France
[16] Univ Hosp, Gastroenterol, Dijon, France
[17] Gustave Roussy, Radiol, Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31221-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2305
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [1] Sunitinib and Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma (HCC)- Final Results of a Phase 2 Trial
    Iyer, R.
    Fetterly, G.
    Groman, A.
    Hutson, A.
    Khushalani, N.
    Mohile, S.
    Ashton, E.
    Litwin, A.
    Grande, C.
    Tomaszewski, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S447 - S447
  • [2] Advanced hepatocellular carcinoma (HCC) treated with sunitinib (Su) and transarterial chemoembolization (TACE): Phase II trial final report
    Iyer, Renuka V.
    Tomaszewski, Garin
    Wu, Yuhsin V.
    Kuvshinoff, Boris W.
    Groman, Adrienne E.
    Khushalani, Nikhil I.
    Grande, Catherine
    Zagst, Patricia D.
    Clark, Kimberly
    Fetterly, Gerald J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial.
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Ikeda, Masafumi
    Torimura, Takuji
    Tanabe, Nobukazu
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Nojiri, Shunsuke
    Hino, Keisuke
    Tsumura, Hidetaka
    Kuzuya, Teiji
    Isoda, Norio
    Yasui, Kohichiroh
    Yoshimura, Kenichi
    Okusaka, Takuji
    Furuse, Junji
    Kokudo, Norihiro
    Okita, Kiwamu
    Arai, Yasuaki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial
    Pokuri, Venkata K.
    Tomaszewski, Garin M.
    Ait-Oudhia, Sihem
    Groman, Adrienne
    Khushalani, Nikhil I.
    Lugade, Amit A.
    Thanavala, Yasmin
    Ashton, Edward A.
    Grande, Catherine
    Fetterly, Gerald J.
    Iyer, Renuka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 332 - 338
  • [5] A randomized phase II trial of a drug eluting bead in the treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization
    Lencioni, R.
    Malagari, K.
    Vogl, T.
    Pilleul, F.
    Denys, A.
    Watkinson, A.
    Lammer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Torimura, Takuji
    Tanabe, Nobukazu
    Ikeda, Masafumi
    Aikata, Hiroshi
    Izumi, Namiki
    Yamasaki, Takahiro
    Nojiri, Shunsuke
    Hino, Keisuke
    Tsumura, Hidetaka
    Isoda, Norio
    Yasui, Kohichiroh
    Kuzuya, Teiji
    Okusaka, Takuji
    Furuse, Junji
    Kokudo, Norihiro
    Okita, Kiwamu
    Yoshimura, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] TREATMENT OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC) BY LIPIODOL-TARGETED TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) - A MULTICENTER RANDOMIZED TRIAL
    BEAUGRAND, M
    HEPATOLOGY, 1993, 18 (04) : A58 - A58
  • [8] Three-dimensional conformal radiotherapy (3DCRT) combined with transcatheter arterial chemoembolization (TACE) for inoperable or unresectable hepatocellular carcinoma (HCC): Clinical phase I/II trial
    Jiang, G
    Zhou, Z
    Liu, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S160 - S161
  • [9] A trial of Zadaxin® (thymalfasin) with trans arterial chemoembolization (TACE) in the treatment of adult patients with unresectable hepatocellular carcinoma:: a phase II trial
    Gish, Robert
    Rustgi, Vinod
    Nelson, David
    Gordon, Stuart
    Rudolph, Alfred
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A74 - A74
  • [10] Transcatheter arterial chemoembolization therapy (TACE) for patients with hepatocellular carcinoma (HCC): A comparative study using a matched untreated cohort
    Biselli, M
    Gramenzi, A
    Cursaro, C
    Rossellini, SR
    Rossi, C
    Stefanini, GF
    Trevisani, F
    Bernardi, M
    Andreone, P
    JOURNAL OF HEPATOLOGY, 2002, 36 : 213 - 214
12345